Millipore Sigma Vibrant Logo

OP181 Anti-ΔNp73 Mouse mAb (38C674)

This Anti-ΔNp73 Mouse mAb (38C674) is validated for use in Immunoblotting for the detection of ΔNp73.

Anti-ΔNp73 Mouse mAb (38C674): MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.
View Products on Sigmaaldrich.com
OP181
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

Species ReactivityHostAntibody Type
HMMonoclonal Antibody

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
OP181-100UG
Verifica della disponibilità in corso...
—
Adempimento e consegna in ritardo Adempimento e consegna in ritardo
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fiala di plastica 100 μg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewRecognizes the ~73 kDa ΔNp73 protein.
      Catalogue NumberOP181
      Brand Family Calbiochem®
      Application Data
      Detection of ΔNp73 by immunoblotting. Samples: Whole cell lysates from transfected with ΔNp73 cDNA cell line (lane A), HeLa cells (lane B) and NIH 3T3 cells (lane C) cell lysates. Primary antibody: Anti-ΔNp73 Mouse mAb (38C674) (Cat. No. OP181) (1 µg/ml). Detection: chemiluminescence.
      References
      ReferencesLevrero, M., et al. 2000 J. Cell Sci. 113, 1661.
      Yang, A., et al. 2000. Nature 404, 99.
      Ueda, Y., et al. 1999. Oncogene 18, 4993.
      Kaghad, M., et al. 1997. Cell 90, 809.
      Product Information
      FormLiquid
      FormulationIn PBS, 0.2% gelatin.
      Positive controlCell lines transfected with ΔNp73
      Preservative≤0.1% sodium azide
      Quality SegmentMQ100
      Applications
      Key Applications Immunoblotting (Western Blotting)
      Application NotesImmunoblotting (1 µg/ml, chemiluminescence)
      Application CommentsDoes not cross-react with full-length p73. Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogena synthetic peptide (LYVGDPARHLAT) corresponding to amino acids 2-13 of human ΔNp73
      ImmunogenHuman
      Clone38C674
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade ITEM Number
      Numero di catalogo GTIN
      OP181-100UG 04055977208856

      Documentation

      Anti-ΔNp73 Mouse mAb (38C674) MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Anti-ΔNp73 Mouse mAb (38C674) Certificati d'Analisi

      TitoloNumero di lotto
      OP181

      Riferimenti bibliografici

      Panoramica delle referenze
      Levrero, M., et al. 2000 J. Cell Sci. 113, 1661.
      Yang, A., et al. 2000. Nature 404, 99.
      Ueda, Y., et al. 1999. Oncogene 18, 4993.
      Kaghad, M., et al. 1997. Cell 90, 809.

      Citazioni

      Titolo
    • Gemma Dominguez, et al. (2006) Δ-TAp73 Upregulation Correlates With Poor Prognosis in Human Tumors: Putative In Vivo Network Involving p73 Isoforms, p53, and E2F-1. Journal of Clinical Oncology 24, 805-815.
      		•
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-October-2007 RFH
      ApplicationImmunoblotting (1 µg/ml, chemiluminescence)
      Application Data
      Detection of ΔNp73 by immunoblotting. Samples: Whole cell lysates from transfected with ΔNp73 cDNA cell line (lane A), HeLa cells (lane B) and NIH 3T3 cells (lane C) cell lysates. Primary antibody: Anti-ΔNp73 Mouse mAb (38C674) (Cat. No. OP181) (1 µg/ml). Detection: chemiluminescence.
      DescriptionPurified mouse monoclonal antibody. Recognizes the ~73 kDa p73 protein lacking the N-terminal transactivation domain, ΔpNp73.
      Backgroundp73 is a relative of tumor suppressor protein p53. It displays a high homology with p53 and with p63, a gene implicated in the maintenance of epithelial stem cells. Significant homology between p53, p63, and p73 suggests that they may have overlapping functions involved in the regulation of gene expression. The disruption of p73 leads to hippocampal dysgenesis, hydrocephalus, chronic inflammation, and infections. Splicing variant mRNAs of p73 have been identified in MCF7, a breast carcinoma cell line. These mRNAs code for variant p73 proteins bearing distinct carboxyl-terminal structures, suggesting that this region of p73 may be important for the functions of this protein. Researchers have recently cloned a p73 variant that lacks an amino-terminal transactivation domain, called ΔNp73. The ΔNp73 message is transcribed from an alternative promoter located in intron 3.
      HostMouse
      Immunogen speciesHuman
      Immunogena synthetic peptide (LYVGDPARHLAT) corresponding to amino acids 2-13 of human ΔNp73
      Clone38C674
      IsotypeIgG₁
      Specieshuman
      Positive controlCell lines transfected with ΔNp73
      FormLiquid
      FormulationIn PBS, 0.2% gelatin.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      CommentsDoes not cross-react with full-length p73. Antibody should be titrated for optimal results in individual systems.
      Storage Avoid freeze/thaw
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Toxicity Standard Handling
      ReferencesLevrero, M., et al. 2000 J. Cell Sci. 113, 1661.
      Yang, A., et al. 2000. Nature 404, 99.
      Ueda, Y., et al. 1999. Oncogene 18, 4993.
      Kaghad, M., et al. 1997. Cell 90, 809.
      Citation
    • Gemma Dominguez, et al. (2006) Δ-TAp73 Upregulation Correlates With Poor Prognosis in Human Tumors: Putative In Vivo Network Involving p73 Isoforms, p53, and E2F-1. Journal of Clinical Oncology 24, 805-815.
      		•